Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrey S Borisov, MD, MPH
U.S. Centers for Disease Control and Prevention (CDC), Atlanta, USA.
Study Director - Robert Belknap, MD
Division of Infectious Diseases, University of Colorado, Denver, USA.
Principal Investigator - Robert Belknap, MD
Division of Infectious Diseases, University of Colorado, Denver, USA.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tb and Chest Service of Hong Kong
Hong Kong, China
- Wits Health Consortium
Soweto, South Africa
- Agencia de Salut Publica - Barcelona, Spain and Unthsc
Barcelona, Spain
- University of California, San Francisco
San Francisco, California, United States
- Denver Public Health Department
Denver, Colorado, United States
- Washington Dc Veterans Affairs Medical Center
Washington D.C., District of Columbia, United States
- Columbia University College of Physicians and Surgeons and New York City Department of Health
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Vanderbilt University Medical Center and Nashville Metro Public Health Department
Nashville, Tennessee, United States
- University of North Texas Health Science Center at Fort Worth
Fort Worth, Texas, United States
- Audie L. Murphy Va Hospital
San Antonio, Texas, United States
- South Texas - Department of State Health Services
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 31 Oct 2014
- Completion
- 31 Oct 2014
- Last update posted
- 13 Mar 2025
- Registered enrollment
- 1,002
- Registry id
- NCT01582711
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.